Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 12, 2026, 12:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 2,612 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Clear all

Conditions: Type 1 Diabetes
Interventions: Not listed
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 3 Years to 17 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 6
States / cities: Stanford, California • Aurora, Colorado • New Haven, Connecticut + 3 more

Conditions: End-Stage Renal Disease, Type 2 Diabetes
Interventions: Dexcom Real-time G6 Continuous Glucose Monitoring System (CGM), POC Glucose Testing; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Biliary Atresia
Interventions: Not listed
Lead sponsor: Arbor Research Collaborative for Health; Other
Eligibility: Up to 6 Months
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2029
U.S. locations: 15
States / cities: Los Angeles, California • San Francisco, California • Aurora, Colorado + 12 more

Conditions: Sitosterolemia
Interventions: High/Low Sitosterol; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2018
U.S. locations: 2
States / cities: Bethesda, Maryland • Lancaster, Pennsylvania

Conditions: Circadian Rhythm Sleep Disorder of Shift Work Type, Metabolic Disease, Insulin Sensitivity
Interventions: Time-restricted feeding, Circadian Misalignment; Behavioral
Lead sponsor: Colorado State University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Pouchitis
Interventions: Electronic Barostat; Procedure
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2007
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Ulcerative Colitis
Interventions: mesalamine; Drug
Lead sponsor: James Lewis; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 8
States / cities: Naples, Florida • Winter Park, Florida • Atlanta, Georgia + 5 more

Conditions: Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia
Interventions: Exercise, Calls and Newsletter; Behavioral · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 60 Years and older · Male only
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Nutrition, Food Selection, Food Preferences, Dietary Habits, Healthy Diet
Interventions: Positive Labels, Spectrum Labels, FDA High In Labels, FDA Traffic Light Labels; Behavioral
Lead sponsor: Harvard Pilgrim Health Care; Other
Eligibility: 18 Years and older
Enrollment: 6,002 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Nervous System, Diabetic Kidney Disease, Diabetes Mellitus, Type 2
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Obesity, Overweight
Interventions: Standard Behavioral Treatment, SBT+LOV; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 55 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pain, Visceral Pain, Pancreatic Cancer
Interventions: Transcranial Magnetic Stimulation; Procedure
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 1 Diabetes
Interventions: Neulasta (Pegylated), Placebo, Mixed Meal Tolerance Test (MMTT), Blood test, DNA Test; Drug · Dietary Supplement · Other
Lead sponsor: University of Florida; Other
Eligibility: 12 Years to 45 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Renal Insufficiency, Chronic, Hypertension
Interventions: Texting, mHealth app; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: End Stage Renal Disease, End-Stage Kidney Disease, Kidney Transplantation, Esrd
Interventions: Kidney Offer Shared Decision Making; Behavioral
Lead sponsor: Hennepin Healthcare Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Rochester, Minnesota

Conditions: Interstitial Cystitis, Painful Bladder Syndrome
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 13 Years and older
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chronic Kidney Disease, End-stage Renal Disease
Interventions: Group-Based (GB) Intervention, Home-Based (HB) Intervention; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 21 Years to 80 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Crohn Disease
Interventions: Anti-TNF therapy; Drug
Lead sponsor: Connecticut Children's Medical Center; Other
Eligibility: 6 Years to 17 Years
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 22
States / cities: Phoenix, Arizona • Los Angeles, California • San Diego, California + 19 more

Conditions: Chronic Kidney Diseases, Hypertension
Interventions: Computerized CKD Education, Usual Hospital Care; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver
Interventions: OA-235i (4 mg), OA-235i (8 mg), OA-235i (16 mg), OA-235i (30 mg), OA-235i (40 mg), OA-235i or placebo; Drug
Lead sponsor: Oasis Pharmaceuticals, LLC; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cystinuria, Nephrolithiasis, Calcium Oxalate
Interventions: Cystone, Sugar Pill (Placebo); Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 100 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acute Kidney Injury, Renal Replacement Therapy, Pediatric Intensive Care Units
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Months to 25 Years
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2029
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: FSGS, Proteinuria
Interventions: Rituximab; Drug
Lead sponsor: George W. Burke; Other
Eligibility: 7 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions: Standard of care treatment, eculizumab; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)

A Prospective Database of Infants With Cholestasis

The Effect of Dietary Sitosterol on Blood Sugar and Cholesterol

Countermeasures to Circadian Misalignment

Clinical Approaches to Ileal Pouch Dysfunction

Dose Escalation and Remission (DEAR)

PRescription Exercise for Older Men With Urinary Disease

Front-of-Package Nutrition Labels

Mechanisms of Diabetic Kidney Disease in American Indians

Preference and Vegetarian Diet in Weight Loss Treatment

TMS for the Treatment of Pancreatic Cancer Pain

Neulasta in Type 1 Diabetes

Supporting Self-Management of Healthy Behaviors in Chronic Kidney Disease

Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision

Genetics of Interstitial Cystitis

A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Interactive Computer-adaptive Chronic Kidney Disease Education Program

Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis

Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones

Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric AKI

Rituximab to Prevent Recurrence of Proteinuria

Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab